Platelet Protection Solution Having a Beta-Galactosidase Inhibitor

The present invention relates to a platelet protection solution (PPS) having an amount of one or more -galactosidase inhibitors with or without an amount of one or more sialidase inhibitors, and optionally one or more glycan-modifying agents; and one or more of PPS components that include a salt, a...

Full description

Saved in:
Bibliographic Details
Main Author LIU QIYONG PETER
Format Patent
LanguageEnglish
Published 26.05.2016
Subjects
BEER
BIOCHEMISTRY
CHEMISTRY
COMPOSITIONS THEREOF
CULTURE MEDIA
ENZYMOLOGY
METALLURGY
MICROBIOLOGY
MICROORGANISMS OR ENZYMES
MUTATION OR GENETIC ENGINEERING
PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS
SPIRITS
VINEGAR
WINE
Online AccessGet full text

Cover

More Information
Summary:The present invention relates to a platelet protection solution (PPS) having an amount of one or more -galactosidase inhibitors with or without an amount of one or more sialidase inhibitors, and optionally one or more glycan-modifying agents; and one or more of PPS components that include a salt, a citrate source, a carbon source, or any combination thereof.
Bibliography:Application Number: US201615013291